Triple semicircular canal occlusion for the treatment of Ménière's disease

Acta Oto-Laryngologica

Volumn 128, Issue 7, 2008, Pages 739-743

  Yin, Shankai ^a   Chen, Zhengnong ^a   Yu, Dongzhen ^a   Wu, Yaqin ^a   Shi, Haibo ^a   Zhou, Huiqun ^a   Wang, Jian ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

M ni re's disease; Triple semicircular canal occlusion

Indexed keywords

ADULT; ARTICLE; CALORIC VESTIBULAR TEST; CASE REPORT; CONTROLLED STUDY; DECOMPRESSION; ENDOLYMPHATIC SAC; FEMALE; FOLLOW UP; HEARING TEST; HUMAN; MALE; MENIERE DISEASE; NYSTAGMUS; PRIORITY JOURNAL; SEMICIRCULAR CANAL; SHUNTING; SURGICAL TECHNIQUE; TRIPLE SEMICIRCULAR CANAL OCCLUSION; TYMPANOMETRY; VERTIGO; VESTIBULAR FUNCTION;

AUDIOMETRY, PURE-TONE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEARING; HUMANS; MALE; MENIERE DISEASE; MIDDLE AGED; OTOLOGIC SURGICAL PROCEDURES; RETROSPECTIVE STUDIES; SEMICIRCULAR CANALS; TIME FACTORS; TREATMENT OUTCOME; VERTIGO;

EID: 45849123526     PISSN: 00016489     EISSN: 16512553     Source Type: Journal    
DOI: 10.1080/00016480701730000     Document Type: Article

References (29)

1. da Costa SS, de Sousa LC, Piza MR. Meniere's disease: overview, epidemiology, and natural history. Otolaryngol Clin North Am 2002;35:455-95.
2. Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of Meniere's disease. Otolaryngol Clin North Am 2002;35:529-45, vi.
3. Minor LB, Schessel DA, Carey JP. Meniere's disease. Curr Opin Neurol 2004;17:9-16.
4. Morel N, Dumas G, Nguyen DQ, Mohr E, Hitter A, Schmerber S. [Vestibular neurotomy versus chemical labyrinthectomy for disabling Meniere disease]. Ann Otolaryngol Chir Cervicofac 2005;122:271-80 (in French).
5. Thai-Van H, Bounaix MJ, Fraysse B. Meniere's disease: pathophysiology and treatment. Drugs 2001;61:1089-102.
6. Lange G, Mann W, Maurer J. [Intratympanic interval therapy of Meniere disease with gentamicin with preserving cochlear function]. HNO 2003;51:898-902.
7. Hoffmann KK, Silverstein H. Inner ear perfusion: indications and applications. Curr Opin Otolaryngol Head Neck Surg 2003;11:334-9.
8. Berryhill WE, Graham MD. Chemical and physical labyrinthectomy for Meniere's disease. Otolaryngol Clin North Am 2002;35:675-82.
9. Abou-Halawa AS, Poe DS. Efficacy of increased gentamicin concentration for intratympanic injection therapy in Meniere's disease. Otol Neurotol 2002;23:494-502; discussion 502-3.
10. Quaranta A, Piazza F. [Meniere's disease: diagnosis and new treatment perspectives]. Recenti Prog Med 2000;91:33-7 (in Italian).
11. Harner SG, Kasperbauer JL, Facer GW, Beatty CW. Transtympanic gentamicin for Meniere's syndrome. Laryngoscope 1998;108:1446-9.
12. Chia SH, Gamst AC, Anderson JP, Harris JP. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol Neurotol 2004;25:544-52.
13. Murofushi T, Halmagyi GM, Yavor RA. Intratympanic gentamicin in Meniere's disease: results of therapy. Am J Otol 1997;18:52-7.
14. Leone CA, Mosca F, Mincione A. [Ablation therapy with gentamicin in the treatment of Meniere's disease]. Acta Otorhinolaryngol Ital 2000;20:322-9.
15. Hirsch BE, Kamerer DB. Role of chemical labyrinthectomy in the treatment of Meniere's disease. Otolaryngol Clin North Am 1997;30:1039-49.
16. Nedzelski JM, Schessel DA, Bryce GE, Pfleiderer AG. Chemical labyrinthectomy: local application of gentamicin for the treatment of unilateral Meniere's disease. Am J Otol 1992;13:18-22.
17. Magnusson AK, Lindstrom S, Tham R. GABA(B) receptors contribute to vestibular compensation after unilateral labyrinthectomy in pigmented rats. Exp Brain Res 2000;134:32-41.
18. Parnes LS, Agrawal SK, Atlas J. Diagnosis and management of benign paroxysmal positional vertigo (BPPV). CMAJ 2003;169:681-93.
19. Agrawal SK, Parnes LS. Human experience with canal plugging. Ann N Y Acad Sci 2001;942:300-5.
20. Parnes LS, McClure JA. Posterior semicircular canal occlusion in the normal hearing ear. Otolaryngol Head Neck Surg 1991;104:52-7.
21. Parnes LS, McClure JA. Posterior semicircular canal occlusion for intractable benign paroxysmal positional vertigo. Ann Otol Rhinol Laryngol 1990;99:330-4.
22. Yin S, Yu D, Li M, Wang J. Triple semicircular canal occlusion in guinea pigs with endolymphatic hydrops. Otol Neurotol 2006;27:78-85.
23. Yin S, Yu D, Chen Z, Cao Z, Wang J. Important factors for the hearing loss caused by the triple semicircular canal occlusion in guinea pigs. Otol Neurotol 2007;28:513-9.
24. Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181-5.
25. Ghossaini SN, Wazen JJ. An update on the surgical treatment of Meniere's diseases. J Am Acad Audiol 2006;17:38-44.
26. Marzo SJ, Leonetti JP. Intratympanic gentamicin therapy for persistent vertigo after endolymphatic sac surgery. Otolaryngol Head Neck Surg 2002;126:31-3.
27. Kuppers P, Ahrens H, Blessing R. [Continuous intratympanic gentamicin infusion in Meniere disease]. HNO 1994;42:429-33.
28. Beck C, Schmidt CL. 10 years of experience with intratympanically applied streptomycin (gentamicin) in the therapy of Morbus Meniere. Arch Otorhinolaryngol 1978;221:149-52.
29. Morgenstern C, Zabel A, Lamprecht J. [Pathogenesis and clinical aspects of Meniere disease. A study of 739 patients]. HNO 1983;31:140-3.